1 Min Read
Jan 12 (Reuters) - Immunogen Inc
* On January 11, 2017, company said that its cash balance at December 31, 2016 (unaudited) was approximately $160 million - SEC filing Source text (bit.ly/2jI3xFH) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.